Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C2CD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR4271 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMCR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SYNPO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RETNLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01527 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KDM5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on